Guselkumab,Golimumab
Janssen
['ibd', 'janssen']
we ve presented new data on a combination therapy for #ulcerativecolitis at this year s #uegweek. learn more about our recent study and janssen s continuous innovation in the #ibd space at the link below. 
Official Twitter site of JanssenUS, to inform media about company news.  Tweets by our communications team. Review our guidelines here: https://t.co/WrVM19L6Yn